| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |